Lavipharm (ATH:LAVI) Scaled Net Operating Assets : 0.64 (As of Jun. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lavipharm's operating assets for the quarter that ended in Jun. 2024 was €114.84 Mil. Lavipharm's operating liabilities for the quarter that ended in Jun. 2024 was €41.14 Mil. Lavipharm's Total Assets for the quarter that ended in Dec. 2023 was €114.79 Mil. Therefore, Lavipharm's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.64.

Lavipharm Scaled Net Operating Assets Historical Data

The historical data trend for Lavipharm's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Scaled Net Operating Assets Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.58

0.51

1.12

0.58

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial						0.48	1.08	0.54	0.57	0.64

Competitive Comparison of Lavipharm's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lavipharm's Scaled Net Operating Assets falls into.

Lavipharm Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lavipharm's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(106.348	-	39.643)	/	114.168
=	0.58

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	114.786	-	8.438
=	106.348

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	72.016	-	23.696	-	8.677
=	39.643

Lavipharm's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(114.835	-	41.138)	/	114.786
=	0.64

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	123.526	-	8.691
=	114.835

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	72.343	-	22.321	-	8.884
=	41.138

Lavipharm Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Lavipharm's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines